BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 17378846)

  • 41. Tadalafil (Cialis) for men with erectile dysfunction.
    Eardley I; Cartledge J
    Int J Clin Pract; 2002 May; 56(4):300-4. PubMed ID: 12074215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vardenafil for the treatment of erectile dysfunction in men with diabetes].
    Wang X
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):794-7. PubMed ID: 15562798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluating the treatment satisfaction of vardenafil in men with erectile dysfunction and female partners by the Treatment Satisfaction Scale].
    Deng CH; Sun XZ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):716-9. PubMed ID: 16209218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy and safety of vardenafil in the treatment of erectile dysfunction in men with hypertension].
    Li HJ
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):953-6. PubMed ID: 17121032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
    Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH;
    Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vardenafil treatment for erectile dysfunction.
    Crowe SM; Streetman DS
    Ann Pharmacother; 2004 Jan; 38(1):77-85. PubMed ID: 14742800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tadalafil and patients preference in the treatment of erectile dysfunction].
    Hu JL; Chen B
    Zhonghua Nan Ke Xue; 2006 Dec; 12(12):1145-8. PubMed ID: 17201266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study.
    Cairoli C; Reyes LA; Henneges C; Sorsaburu S
    Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA; Isidori AM; Gravina GL; Aversa A; Balercia G; Bocchio M; Boscaro M; Carani C; Corona G; Fabbri A; Foresta C; Forti G; Francavilla S; Granata AR; Maggi M; Mansani R; Palego P; Spera G; Vetri M; Lenzi A;
    J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy and safety of vardenafil in men with erectile dysfunction and depression].
    Hu L
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):876-9. PubMed ID: 15595695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vardenafil significantly alleviates erectile dysfunction in aged men with diabetes].
    Zhang ZL; Li HJ; Zhen WH; Yuan R
    Zhonghua Nan Ke Xue; 2008 Aug; 14(8):737-9. PubMed ID: 18817350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
    Fusco F; Sicuteri R; Rossi A; Kontodimas S; Haro JM; Imbimbo C; Mirone V;
    Asian J Androl; 2009 Sep; 11(5):629-37. PubMed ID: 19701217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; DamiĆ£o R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global experiences with vardenafil in men with erectile dysfunction and underlying conditions.
    Eardley I; Lee JC; Guay AT
    Int J Clin Pract; 2008 Oct; 62(10):1594-603. PubMed ID: 18822030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of phosphodiesterase type 5 (PDE5) inhibitors.
    Wright PJ
    Int J Clin Pract; 2006 Aug; 60(8):967-75. PubMed ID: 16780568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reliable efficacy of vardenafil for treatment of erectile dysfunction].
    Meng FL
    Zhonghua Nan Ke Xue; 2006 Jul; 12(7):666-8. PubMed ID: 16894950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
    Tan HM; Chin CM; Chua CB; Gatchalian E; Kongkanand A; Moh CL; Ng FC; Ratana-Olarn K; Serrano D; Taher A; Tambi I; Tantiwong A; Chen MW; Yip WC
    Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.